Alison Wei
Vice President, Investor Relations
Replay available
Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John Shannon
Chief Executive Officer
Alex von Reesman
Analyst, Piper Sandler
Georgia Bank
Analyst, Jefferies (for Dennis Ding)
Steve Piper
Chief Financial Officer
Jason Dorr
Analyst, Oppenheimer
Chase Knickerbocker
Analyst, Craig Hallum
Brandon Folks
Analyst, H.C. Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Xeris Biopharma Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.636 Good morning and welcome to the Xeris Biopharma Q126 00:00:04.636 -- 00:00:07.179 Earnings Conference Call. 00:00:07.179 -- 00:00:12.645 Please note that before we begin, this conference is being recorded on Thursday, 00:00:12.645 -- 00:00:17.711 May 7th at 8.30 a.m. I will now pass the call over to 00:00:17.711 -- 00:00:22.116 Alison Wei for opening remarks. Please go ahead. 00:00:22.116 -- 00:00:26.805 Thank you, Sarah. Good morning, everyone, and welcome to Xeris' first quarter financial 00:00:26.805 -- 00:00:31.455 results conference call. Earlier this morning, we issued a press release detailing our 00:00:31.455 -- 00:00:35.022 first quarter 2026 financial and operating results. 00:00:35.022 -- 00:00:37.831 This press release can be found on our website. 00:00:37.831 -- 00:00:43.061 Joining me today is John Shannon, our Chief Executive Officer, and Steve Piper, our 00:00:43.061 -- 00:00:47.409 Chief Financial Officer. Following our prepared remarks, we will open the call for your 00:00:47.409 -- 00:00:52.780 questions. Before we begin, I'd like to remind you that today's discussion will include 00:00:52.780 -- 00:00:58.230 forward-looking statements regarding Xeris's future expectations, plans, strategies, 00:00:58.230 -- 00:01:02.317 objectives, and financial performance. These forward-looking statements are based on 00:01:02.317 -- 00:01:06.785 management's current assumptions and beliefs and are subject to a number of risks and 00:01:06.785 -- 00:01:11.533 uncertainties that could cause actual results to differ materially from those expressed 00:01:11.533 -- 00:01:16.482 or implied. For discussion of these risks and uncertainties, please refer to the risk 00:01:16.482 -- 00:01:19.681 factors described in our filings with th...